Nanobiotix (NBTX) Receivables - Other (2019 - 2024)

Historic Receivables - Other for Nanobiotix (NBTX) over the last 5 years, with Q4 2024 value amounting to $3.2 million.

  • Nanobiotix's Receivables - Other rose 10830.03% to $3.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.2 million, marking a year-over-year increase of 10830.03%. This contributed to the annual value of $3.2 million for FY2024, which is 10985.24% up from last year.
  • As of Q4 2024, Nanobiotix's Receivables - Other stood at $3.2 million, which was up 10830.03% from $1.5 million recorded in Q4 2023.
  • Nanobiotix's Receivables - Other's 5-year high stood at $3.2 million during Q4 2024, with a 5-year trough of $1.1 million in Q4 2020.
  • Moreover, its 4-year median value for Receivables - Other was $2.2 million (2023), whereas its average is $2.1 million.
  • In the last 5 years, Nanobiotix's Receivables - Other tumbled by 4544.31% in 2023 and then skyrocketed by 10830.03% in 2024.
  • Nanobiotix's Receivables - Other (Quarter) stood at $1.1 million in 2020, then skyrocketed by 154.94% to $2.8 million in 2022, then tumbled by 45.44% to $1.5 million in 2023, then surged by 108.3% to $3.2 million in 2024.
  • Its Receivables - Other was $3.2 million in Q4 2024, compared to $1.5 million in Q4 2023 and $2.8 million in Q4 2022.